Overview
- Legal name
- IMMUNO MYCOLOGIES INC
- Registered location
- NORMAN, OK, USA
- Website
- Company website ↗
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- Latest award activity
- Jun 24, 2026
Read company summary
IMMUNO MYCOLOGIES INC is associated with UEI CN4DMLCJGCK9 and CAGE 3U927 in public federal records. AcornBids currently links 9 prime awards totaling $2.5M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology); In-Vitro Diagnostic Substance Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325413 (In-Vitro Diagnostic Substance Manufacturing). Its public SAM.gov registration lists NORMAN, OK, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 8, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- IMMUNO MYCOLOGIES INC
- UEI
- CN4DMLCJGCK9
- CAGE
- 3U927
- Registered address
- 2701 CORPORATE CENTRE DR, NORMAN, OK, 73069, USA
- Registration status
- Active
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- SAM activation
- Jul 20, 2026
- Initial registration
- May 27, 1999
- Entity start
- Jul 1, 1979
- SAM updated
- Jul 20, 2026
- Registration expires
- Jul 16, 2027
- Fiscal year end
- Jun 30
- Place of incorporation
- OK, USA
Research brief
Source facts
- Loaded prime-award records link 9 awards and $2,494,076 in reported obligations to this legal entity. Source
- Recorded awards include Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714); this classification is not proof of every company capability. Source
- An example award describes: REQUIREMENT FOR IMMUNO MYCOLOGIES CF SUPPLIES PROCUREMENT Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 9 of 9 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $171.0K |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $292.9K |
| Change | $-121.9K |
| Growth | -41.6% |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Health and Human Services | $1.4M | 2 |
| Department of Veterans Affairs | $553.6K | 7 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| NATIONAL INSTITUTES OF HEALTH NIAID | $1.4M | 2 |
| 249-NETWORK CONTRACT OFFICE 9 (36C249) | $378.1K | 4 |
| 262-NETWORK CONTRACT OFFICE 22 (36C262) | $175.4K | 3 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | $1.4M | 2 |
| 325413 — In-Vitro Diagnostic Substance Manufacturing | $553.6K | 7 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $1.4M | 2 |
| 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets | $294.3K | 5 |
| 6515 — Medical and Surgical Instruments, Equipment, and Supplies | $259.3K | 2 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $1.7M | 4 |
| 36C26222A0042 | $175.4K | 3 |
| 36C24926A0032 | $118.8K | 1 |
| 36C24924D0034 | $-3 | 1 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| SMALL BUSINESS SET ASIDE - TOTAL | $1.4M | 2 |
| NO SET ASIDE USED. | $553.6K | 6 |
| Unclassified | $-3 | 1 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 36C24925P0274REQUIREMENT FOR IMMUNO MYCOLOGIES CF SUPPLIES PROCUREMENT | Department of Veterans Affairs | $134.2K | Jan 19, 2025 | Jan 18, 2026 |
| 36C26226N0595OPTION YEAR 4 FUNDING | Department of Veterans Affairs | $89.4K | Jun 27, 2026 | Jun 26, 2027 |
| 36C24926N0334FUNGAL COMPLEMENT FIXATION AND IMMUNODIFFUSION TESTING | Department of Veterans Affairs | $118.8K | Mar 19, 2026 | Jan 18, 2027 |
| 36C26224N0800COCCIDIOSIS ANTIBODY REAGENT TEST KITS | Department of Veterans Affairs | $83.6K | Jun 27, 2024 | Jun 26, 2025 |
| 75N93020C00033DEVELOPMENT AN EASY-TO-USE DIAGNOSTIC TEST CAPABLE OF EARLY, RAPID DETECTION OF TALAROMYCES ANTIGEN IN HUMAN SERUM, PLASMA, AND/OR URINE. | Department of Health and Human Services | $210.0K | Sep 25, 2020 | Sep 24, 2021 |
| 36C24925P0444REQUIREMENT FOR IMMUNO MYCOLOGIES CF SUPPLIES PROCUREMENT | Department of Veterans Affairs | $125.1K | Apr 30, 2025 | Sep 30, 2025 |
| 36C26225N0826COCCIDIOSIS ANTIBODY REAGENT TEST KITS | Department of Veterans Affairs | $86.8K | Jun 27, 2025 | Jun 26, 2026 |
| 75N93022C00027DEVELOPMENT AND VALIDATION OF THE ENZYME IMMUNOASSAYS (EIA) DETECTING TALAROMYCES MP1P ANTIGEN. A RAPID AND ACCURATE IN-HOUSE EIA DETECTING TALAROMYCES MARNEFFEI IN A PHASE II | Department of Health and Human Services | $1.5M | Sep 30, 2022 | Sep 29, 2025 |
| 36C24924N0259COMPLEMENT FIXATION TESTING, CONTROLS AND REAGENTS | Department of Veterans Affairs | $146.6K | Jan 19, 2024 | Jan 18, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jul 20, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | May 27, 1999 |
| Entity start | Jul 1, 1979 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325413 — In-Vitro Diagnostic Substance Manufacturing | Not reported |
| 424210 — Drugs and Druggists' Sundries Merchant Wholesalers | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| DEVIN MOXLEY | Government business | Contact method not published | SAM registration | Not available |
| SEAN BAUMAN | Alternate government business | Contact method not published | SAM registration | Not available |
| DEVIN MOXLEY | Electronic business | Contact method not published | SAM registration | Not available |
| SEAN BAUMAN | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- 424210 — Drugs and Druggists' Sundries Merchant Wholesalers
Registered products and services
- 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit